emergency
medical help
signs of an allergic reaction
hives
difficult breathing
swelling
face
lips
tongue
throat
using
using esterified estrogens
active ingredient
menest
doctor
signs of a stroke
sudden numbness
weakness
side of the body
sudden severe headache
speech
problems with vision
balance
signs of a blood clot in the lung
chest pain
sudden cough
wheezing
rapid breathing
coughing
blood
signs of a blood clot
leg
pain
swelling
warmth
redness
legs
heart attack symptoms
chest pain
pressure
pain
jaw
shoulder
nausea
sweating
liver problems
severe stomach pain
fever
tired feeling
loss of appetite
dark urine
clay-colored stools
jaundice
yellowing of the skin
eyes
high levels of calcium
blood
nausea
vomiting
constipation
thirst
urination
muscle weakness
bone pain
confusion
lack of energy
tired feeling
change in the pattern
severity of migraine headaches
swelling
hands
ankles
feet
breast lump
severe skin reaction
fever
sore throat
swelling
face
tongue
burning
eyes
skin pain
purple skin rash
face
upper body
blistering
peeling
common side effects
light vaginal bleeding
spotting
breast pain
tenderness
nausea, vomiting, bloating;
skin color changes
facial hair
thinning scalp hair
headache
dizziness
mood changes
sex drive
vaginal itching
discharge
light menstrual periods
problems with contact lenses
complete list of side effects
others
doctor for medical advice about side effects
rare cases of oral pigmentation
ischemic colitis
gastrointestinal symptoms of nausea
vomiting
reported adverse effects
studies
fold increase in gallbladder disease in postmenopausal women
taking estrogen therapy
oncologic side effects
unopposed estrogen therapy
increased risk of endometrial carcinoma in patients with an intact uterus
increased risk of breast cancer
number of studies
risk of endometrial carcinoma
administration of progestins in combination with estrogen therapy
increased risk of breast cancer
estrogens
several studies
long-term estrogen therapy
increased risk of breast cancer
meta analysis of studies
epidemiological data
modest risk increase
long-term hormone replacement therapy
hrt
study of swedish women
increase in the relative risk of breast cancer
risk
increasing duration of estrogen therapy
study
women with more
years of estrogen use
greater relative risk of breast cancer than controls
study
examined use of a variety of estrogen preparations of which estradiol
addition
women
progestins
decreased risk of breast cancer
higher risk
toronto breast cancer study
women
unopposed conjugated estrogens for less than years
increased risk of breast cancer
study
increase in the risk of breast cancer for women
conjugated estrogens for more than years
case-control surveillance study
evidence that the use of unopposed
unopposed conjugated estrogens
risk of breast cancer
long duration of use
long latent intervals
possibility of a modest increase
doubling
nurses
health study
increased risk of breast cancer in women
taking estrogen replacement therapy
risk
concurrent use of progestins
study
greater risk
advanced age
prolonged duration of hormonal therapy
study of middle-aged women in the puget sound area
whole
use of estrogen with progestin hrt
hormone replacement therapy
increased risk of breast cancer in middle-aged women
prospective cohort study
years
women by gapstur
histology of the breast cancer in women
hrt
association
duration
hrt use
incidence of ductal carcinoma
invasive ductal/lobular carcinoma
duration
hrt use
risk of invasive carcinoma with a favorable prognosis
relative risk
rr
confidence interval
ci
hrt
yrs
rr
ci
hrt
> yrs
p
relative risks of invasive carcinoma with a favorable prognosis for current users
age
other risk factors
ci
yrs
ci
> yrs
risk of invasive ductal
lobular carcinoma for current users
yrs
rr
ci
effect of estrogen therapy
reducing
reducing cardiovascular risk
beneficial alterations in lipid profiles in treated women
reported effects of estrogens on cardiovascular activity
alterations in lipid profiles in treated women
reducing
reducing cardiovascular risks
data
estrogen use
blood pressure
patients
receiving high doses
blood pressure
change
addition
noncontraceptive use of estrogens in young women
smokers
risk of nonfatal myocardial infarction
other studies
increased risk of myocardial infarction
cardiovascular risks
estrogen therapy
studies
unopposed estrogen therapy
risk of coronary heart disease
combination therapy with a progestin
coronary risk
extent of risk reduction with combination therapy
data
combination therapy
overall rate of coronary heart disease in postmenopausal women with established coronary disease
hdl
ldl
total cholesterol levels
estrogen therapy
triglyceride levels
dramatic elevations in triglyceride levels
lesser extent
cholesterol levels
metabolic side effects
been favorable alterations in plasma lipid profiles
hdl
cholesterol
ldl levels
estrogen therapy
increase in serum triglyceride levels
pancreatitis in patients with familial lipoprotein
metabolic defects
hypercalcemia
patients with breast cancer
bone metastases
aggravation of porphyria
estrogens
degree of fluid retention
mastodynia
genitourinary side effects
abnormal uterine bleeding
bleeding
endometrial carcinoma
addition
estrogens
size
preexisting
preexisting uterine leiomyomata
several cases of pseudoincontinence
excessive vaginal discharge
patients as urinary incontinence
post-operative estrogens
hematologic side effects of hypercoagulability
clinical significance of such hypercoagulability in postmenopausal women
taking estrogens
reports of hepatic tumors
women
taking long-term oral contraceptives
tumors
women
taking isolated estrogen therapy
hepatic side effects
rare cases of focal nodular hyperplasia
liver cell adenomas
hepatic hemangiomas
well-differentiated hepatocellular carcinomas
hypersensitivity reactions
anaphylaxis
association with estrogens
dyes
conjugated estrogen formulations
nervous system
side effects
estrogen therapy
migraine
dizziness
mental depression
case of chorea
association
conjugated estrogen therapy
alterations in libido
ocular side effects of estrogen therapy
alterations in corneal curvature
contact lens discomfort
investigators
estrogen therapy
risk
fibrocystic breast disease
psychiatric effects of estrogen use
case reports of rapid mood cycling in patients with severe depression
dermatologic effects
chloasma
melasma
resolution
cases
following discontinuation of estrogen therapy
scalp hair loss
hirsutism
erythema nodosum
hemorrhagic eruptions
endocrine effects of estrogen use
decreased fasting plasma glucose
estrogen use
increased levels of thyroxin-binding globulin
increased total thyroid serum levels
resin uptake of t
free thyroid hormone levels
signs of a stroke
sudden numbness
weakness
side of the body
sudden severe headache
speech
problems with vision
balance
signs of a blood clot in the lung
chest pain
sudden cough
wheezing
rapid breathing
coughing
blood
signs of a blood clot
leg
pain
swelling
warmth
redness
legs
heart attack symptoms
chest pain
pressure
pain
jaw
shoulder
nausea
sweating
liver problems
severe stomach pain
fever
tired feeling
loss of appetite
dark urine
clay-colored stools
jaundice
yellowing of the skin
eyes
high levels of calcium
blood
nausea
vomiting
constipation
thirst
urination
muscle weakness
bone pain
confusion
lack of energy
tired feeling
change in the pattern
severity of migraine headaches
swelling
hands
ankles
feet
breast lump
severe skin reaction
fever
sore throat
swelling
face
tongue
burning
eyes
skin pain
purple skin rash
face
upper body
blistering
peeling
light vaginal bleeding
spotting
breast pain
tenderness
nausea, vomiting, bloating;
skin color changes
facial hair
thinning scalp hair
headache
dizziness
mood changes
sex drive
vaginal itching
discharge
light menstrual periods
problems with contact lenses